Similar Search Results

Does reference pricing drive out generic competition in pharmaceutical markets? : evidence from a policy reform

Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - 2022

more agressive, which triggers price competition and potentially deters entry by generic producers. To investigate the … branded and generic drug prices and branded market shares. Despite fiercer price competition, the number of generic producers …

Persistent link: https://www.econbiz.de/10013285854

The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry

Banerjee, Tannista; Siebert, Ralph - 2014

Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...

Persistent link: https://www.econbiz.de/10010229875

Reference pricing of pharmaceuticals

Brekke, Kurt R. (contributor); … - 2006

Persistent link: https://www.econbiz.de/10003379831

Does pharmaceutical price regulation affect the adoption of generic competition? : evidence from the OECD, 1999-2008

Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - 2011

Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static … adoption of generic competition. This paper aims to investigate how price regulations in the OECD affect the adoption of … generic competition following the first global generic launch of each molecule. Drawing upon data from 1999 to 2008, we …

Persistent link: https://www.econbiz.de/10009124143

Longitudinal analysis of generic substitution

Dalen, Dag Morten; Locatelli Biey, Marilena; Strøm, Steinar - 2010

Using an extensive longitudinal dataset extracted from the Norwegian Prescription Database (NorPD) containing all prescriptions written in the period January 2004 to June 2007, we selected two particular drugs (chemical substances) used against cholesterol. The two brand-name products on the...

Persistent link: https://www.econbiz.de/10008697144

Margins and market shares : pharmacy incentives for generic substitution

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2012

generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …. -- pharmaceuticals ; pharmacies ; generic substitution …

Persistent link: https://www.econbiz.de/10009691207

Reference pricing, competition, and pharmaceutical expenditures : theory and evidence from a natural experiment

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using …-savings, and that patients' copayments decrease despite the extra surcharges under RP. -- pharmaceuticals ; regulation ; generic … competition …